NZ598605A - Vaccine against african horse sickness virus - Google Patents
Vaccine against african horse sickness virusInfo
- Publication number
- NZ598605A NZ598605A NZ598605A NZ59860509A NZ598605A NZ 598605 A NZ598605 A NZ 598605A NZ 598605 A NZ598605 A NZ 598605A NZ 59860509 A NZ59860509 A NZ 59860509A NZ 598605 A NZ598605 A NZ 598605A
- Authority
- NZ
- New Zealand
- Prior art keywords
- african horse
- horse sickness
- sickness virus
- nucleic acid
- acid molecule
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12111—Orbivirus, e.g. bluetongue virus
- C12N2720/12122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12111—Orbivirus, e.g. bluetongue virus
- C12N2720/12134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10807508P | 2008-10-24 | 2008-10-24 | |
| US16351709P | 2009-03-26 | 2009-03-26 | |
| NZ592388A NZ592388A (en) | 2008-10-24 | 2009-10-22 | Vaccine against ahsv |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ598605A true NZ598605A (en) | 2014-04-30 |
Family
ID=41818403
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ592388A NZ592388A (en) | 2008-10-24 | 2009-10-22 | Vaccine against ahsv |
| NZ598605A NZ598605A (en) | 2008-10-24 | 2009-10-22 | Vaccine against african horse sickness virus |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ592388A NZ592388A (en) | 2008-10-24 | 2009-10-22 | Vaccine against ahsv |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US8168200B2 (enExample) |
| EP (1) | EP2358742B1 (enExample) |
| JP (1) | JP2012506699A (enExample) |
| KR (1) | KR101719005B1 (enExample) |
| CN (1) | CN102245627A (enExample) |
| AP (1) | AP3334A (enExample) |
| AR (1) | AR074055A1 (enExample) |
| AU (1) | AU2009308331C1 (enExample) |
| BR (2) | BRPI0920622B1 (enExample) |
| CA (1) | CA2741333C (enExample) |
| CL (1) | CL2011000922A1 (enExample) |
| EA (1) | EA024111B1 (enExample) |
| ES (1) | ES2681693T3 (enExample) |
| MX (1) | MX2011004219A (enExample) |
| NZ (2) | NZ592388A (enExample) |
| PL (1) | PL2358742T3 (enExample) |
| PT (1) | PT2358742T (enExample) |
| WO (1) | WO2010048394A2 (enExample) |
| ZA (1) | ZA201103031B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012506699A (ja) * | 2008-10-24 | 2012-03-22 | メリアル リミテッド | アフリカウマ病ウイルスに対するワクチン |
| AU2013221502C1 (en) | 2012-02-14 | 2018-03-01 | Boehringer Ingelheim Animal Health USA Inc. | Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom |
| AP2016009610A0 (en) * | 2014-11-04 | 2016-12-31 | Deltamune Pty Ltd | Live attenuated african horsesickness virus |
| US11233998B2 (en) * | 2015-05-29 | 2022-01-25 | Qualcomm Incorporated | Coding data using an enhanced context-adaptive binary arithmetic coding (CABAC) design |
| EP3768326A1 (en) * | 2018-03-19 | 2021-01-27 | Boehringer Ingelheim Vetmedica GmbH | Ehv insertion site ul43 |
| CN116041447A (zh) * | 2022-12-29 | 2023-05-02 | 北京亿森宝生物科技有限公司 | 一种检测非洲马瘟病毒的试剂盒及其应用 |
| CN116656731B (zh) * | 2023-05-25 | 2024-04-12 | 军事科学院军事医学研究院军事兽医研究所 | 一种表达非洲猪瘟病毒多种蛋白的重组金丝雀痘病毒及其构建方法 |
| WO2025013146A1 (ja) | 2023-07-07 | 2025-01-16 | 中京油脂株式会社 | 分散体 |
| CN117737310B (zh) * | 2024-01-26 | 2024-07-16 | 中国农业科学院北京畜牧兽医研究所 | 非洲马瘟和西尼罗病毒的双重实时荧光mira检测引物探针组、试剂盒及方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5505941A (en) * | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
| AU672359B2 (en) * | 1991-03-07 | 1996-10-03 | Virogenetics Corporation | Genetically engineered vaccine strain |
| US5843456A (en) | 1991-03-07 | 1998-12-01 | Virogenetics Corporation | Alvac poxvirus-rabies compositions and combination compositions and uses |
| ZA976424B (en) * | 1996-07-05 | 1999-01-22 | Agricultural Research Council | Nucleic acid sequences coding for african horsesickness virus outer capsid components |
| FR2775601B1 (fr) * | 1998-03-03 | 2001-09-21 | Merial Sas | Vaccins vivants recombines et adjuves |
| FR2776928B1 (fr) * | 1998-04-03 | 2000-06-23 | Merial Sas | Vaccins adn adjuves |
| US7740863B2 (en) * | 2001-04-06 | 2010-06-22 | Merial | Recombinant vaccine against West Nile Virus |
| US7862821B2 (en) * | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
| JP2012506699A (ja) * | 2008-10-24 | 2012-03-22 | メリアル リミテッド | アフリカウマ病ウイルスに対するワクチン |
-
2009
- 2009-10-22 JP JP2011533331A patent/JP2012506699A/ja active Pending
- 2009-10-22 AP AP2011005954A patent/AP3334A/xx active
- 2009-10-22 NZ NZ592388A patent/NZ592388A/en unknown
- 2009-10-22 BR BRPI0920622-1A patent/BRPI0920622B1/pt active IP Right Grant
- 2009-10-22 MX MX2011004219A patent/MX2011004219A/es active IP Right Grant
- 2009-10-22 AU AU2009308331A patent/AU2009308331C1/en active Active
- 2009-10-22 NZ NZ598605A patent/NZ598605A/en unknown
- 2009-10-22 WO PCT/US2009/061669 patent/WO2010048394A2/en not_active Ceased
- 2009-10-22 CN CN2009801492091A patent/CN102245627A/zh active Pending
- 2009-10-22 US US12/604,048 patent/US8168200B2/en active Active
- 2009-10-22 CA CA2741333A patent/CA2741333C/en active Active
- 2009-10-22 PT PT97606552T patent/PT2358742T/pt unknown
- 2009-10-22 EA EA201100674A patent/EA024111B1/ru unknown
- 2009-10-22 PL PL09760655T patent/PL2358742T3/pl unknown
- 2009-10-22 EP EP09760655.2A patent/EP2358742B1/en active Active
- 2009-10-22 ES ES09760655.2T patent/ES2681693T3/es active Active
- 2009-10-22 KR KR1020117011832A patent/KR101719005B1/ko active Active
- 2009-10-22 BR BR122019001455-8A patent/BR122019001455B1/pt active IP Right Grant
- 2009-10-23 AR ARP090104083A patent/AR074055A1/es active IP Right Grant
-
2011
- 2011-04-21 CL CL2011000922A patent/CL2011000922A1/es unknown
- 2011-04-21 ZA ZA2011/03031A patent/ZA201103031B/en unknown
-
2012
- 2012-01-25 US US13/357,755 patent/US20120114691A1/en not_active Abandoned
-
2013
- 2013-10-22 US US14/060,023 patent/US20140120133A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ598605A (en) | Vaccine against african horse sickness virus | |
| HRP20191594T1 (hr) | Poticanje imunosnog odgovora | |
| AR122325A2 (es) | Antígeno ndv recombinante y usos del mismo | |
| ES2662801T3 (es) | Vacunas atenuadas contra Streptoccocus suis y procedimientos de fabricación y uso de las mismas | |
| NZ702145A (en) | Bluetongue virus recombinant vaccines and uses thereof | |
| PH12021550030A1 (en) | Nucleotide sequences encoding peptide antigens of sars-cov-2 virus and use thereof | |
| AR061484A1 (es) | Secuencias de adn vectores proteinas y usos de hemaglutinina de gripe aviar | |
| AR124928A2 (es) | Vacuna de herpesvirus-1 equino recombinante que contiene glicoproteína c mutada y usos de la misma | |
| JP2014507146A5 (enExample) | ||
| JP2012515557A5 (enExample) | ||
| NZ735684A (en) | Materials and methods for respiratory disease control in canines | |
| JP2019506175A5 (enExample) | ||
| DE602004028000D1 (de) | Tuberkulose vaccine mit verbesserter effizienz | |
| WO2008156729A3 (en) | Vaccines against chlamydia infection | |
| RU2018122755A (ru) | Слитые белки fmdv-e2 и их применение | |
| JP2012516140A5 (enExample) | ||
| HRP20130022T1 (hr) | Fuzijski proteini koji sadrže antigene ny-eso-1 i lage-1 za odbacivanje tumora | |
| RU2015113826A (ru) | Выделение вируса, родственного парвовирусу-2 собак, от енота | |
| WO2018102774A8 (en) | Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein a | |
| RU2013102413A (ru) | Парапоксвирусные векторы | |
| JP2013504600A5 (enExample) | ||
| RU2012149036A (ru) | Векторы парапоксвируса, содержащие антиген вируса бешенства | |
| ZA202309287B (en) | Coronavirus vaccine comprising a mosaic protein | |
| ATE435660T1 (de) | Immunogenes polypeptid bestehend aus optimierten kryptischen peptiden aus tumorantigenen und seine verwendungen | |
| AR053372A1 (es) | Proteinas inmunologicas de lawsonia intracellularis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 22 OCT 2016 BY FB RICE Effective date: 20140805 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 22 OCT 2017 BY COMPUTER PACKAGES INC Effective date: 20161001 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 22 OCT 2018 BY COMPUTER PACKAGES INC Effective date: 20171003 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 22 OCT 2019 BY COMPUTER PACKAGES INC Effective date: 20181018 |
|
| ASS | Change of ownership |
Owner name: MERIAL, INC., US Effective date: 20190313 Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, US Effective date: 20190313 Owner name: UNIVERSITY OF PRETORIA, ZA Effective date: 20190313 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 22 OCT 2020 BY COMPUTER PACKAGES INC Effective date: 20191001 |
|
| ASS | Change of ownership |
Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC., US Effective date: 20191114 Owner name: UNIVERSITY OF PRETORIA, ZA Effective date: 20191114 Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, US Effective date: 20191114 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 22 OCT 2021 BY COMPUTER PACKAGES INC Effective date: 20201001 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 22 OCT 2022 BY DENNEMEYER + CO. Effective date: 20211011 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 22 OCT 2023 BY DENNEMEYER + CO. Effective date: 20221010 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 22 OCT 2024 BY DENNEMEYER + CO. S.A.R.L. Effective date: 20231009 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 22 OCT 2025 BY DENNEMEYER ET CO Effective date: 20241015 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 22 OCT 2026 BY DENNEMEYER + CO. SARL Effective date: 20251014 |